Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JD Health InternationalJDHIF 90 Return-on-Tangible-Asset is 7.19% as of Dec. 2025, which is 105% above its 10-year median of 3.50. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $9.15. The stock has 1 warning sign investors should review. Among 680 Healthcare Providers & Services companies, JD Health International ranks better than 71.47% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. JD Health International's annualizedNet Income for the quarter that ended in Dec. 2025 was $789 Mil. JD Health International's average total tangible assets for the quarter that ended in Dec. 2025 was $10,977 Mil. Therefore, JD Health International's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 7.19%.
The historical rank and industry rank for JD Health International's Return-on-Tangible-Asset or its related term are showing as below:
JDHIF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -66.15 Med: 3.5 Max: 20.24
Current: 7.22
During the past 9 years, JD Health International's highest Return-on-Tangible-Asset was 20.24%. The lowest was -66.15%. And the median was 3.50%.
JDHIF's Return-on-Tangible-Asset is ranked better than 71.47% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.55
vs JDHIF: 7.22
JD Health International (OTCPK:JDHIF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
JD Health International Return-on-Tangible-Asset Related Terms
JD Health International Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for JD Health International's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Return-on-Tangible-Asset Chart
JD Health International Return-on-Tangible-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where JD Health International's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 7.19% mean?
JD Health International (JDHIF) has a Return-on-Tangible-Asset of 7.19% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on JD Health International and its competitors. This is 105% above median its historical median of 3.50. According to the industry distribution chart, JD Health International ranks #194 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 28.5%.
Is JD Health International's Return-on-Tangible-Asset too high?
JD Health International's current Return-on-Tangible-Asset of 7.19% is 105% above median its 10-year median of 3.50. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.55. JD Health International's value of 7.19% is 182% above this industry median. Based on the distribution chart, JD Health International ranks #194 out of 680 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #194 out of 680 companies for Return-on-Tangible-Asset. This puts JD Health International in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.55. JD Health International's value of 7.19% is 182% above this benchmark. While the company's 10-year median is 3.50 vs. the industry median of 2.55, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.55, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current Return-on-Tangible-Asset of 7.19% is 182% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current Return-on-Tangible-Asset is 7.19%, which is 105% above median its own 10-year median of 3.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current Return-on-Tangible-Asset of 7.19%. The stock's GF Value™ is $9.15, compared to a current price of $5.85 — trading 36.1% below its estimated fair value. The current Return-on-Tangible-Asset is 7.19%, which is 105% above median its 10-year median of 3.50 and 182% above the Healthcare Providers & Services industry median of 2.55. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For JD Health International (JDHIF), the current Return-on-Tangible-Asset is 7.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 36.1% below its estimated GF Value™ of $9.15.
Key valuation signals for JDHIF:
Return-on-Tangible-Asset: 7.19% (105% above median its 10-year median of 3.50)
GF Value™: $9.15 vs. price of $5.85 (36.1% below fair value)
Industry Position: 182% above the Healthcare Providers & Services median (#194 of 680)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for JDHIF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
